Show simple item record

dc.contributor.authorJohnston, Olwyn
dc.contributor.authorCassidy, Hilary
dc.contributor.authorO'Connell, Séin
dc.contributor.authorO'Riordan, Aisling
dc.contributor.authorGallagher, William
dc.contributor.authorMaguire, Patricia B
dc.contributor.authorWynne, Kieran
dc.contributor.authorCagney, Gerard
dc.contributor.authorRyan, Michael P
dc.contributor.authorConlon, Peter J
dc.contributor.authorMcMorrow, Tara
dc.date.accessioned2012-06-20T13:43:47Z
dc.date.available2012-06-20T13:43:47Z
dc.date.issued2011-08
dc.identifier.citationIdentification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods. 2011, 5 (7-8):422-31 Proteomics Clin Applen_GB
dc.identifier.issn1862-8354
dc.identifier.pmid21751411
dc.identifier.doi10.1002/prca.201000160
dc.identifier.urihttp://hdl.handle.net/10147/229912
dc.description.abstractChronic allograft nephropathy (CAN) remains the leading cause of renal graft loss after the first year following renal transplantation. This study aimed to identify novel urinary proteomic profiles, which could distinguish and predict CAN in susceptible individuals.
dc.language.isoenen
dc.rightsArchived with thanks to Proteomics. Clinical applicationsen_GB
dc.subject.meshAdult
dc.subject.meshBiological Markers
dc.subject.meshCase-Control Studies
dc.subject.meshFemale
dc.subject.meshGlomerulonephritis, Membranous
dc.subject.meshGlomerulosclerosis, Focal Segmental
dc.subject.meshHumans
dc.subject.meshKidney
dc.subject.meshKidney Transplantation
dc.subject.meshMiddle Aged
dc.subject.meshProtein Array Analysis
dc.subject.meshProteomics
dc.subject.meshSoftware
dc.subject.meshSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
dc.subject.meshTransplantation, Homologous
dc.subject.meshbeta 2-Microglobulin
dc.titleIdentification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods.en_GB
dc.typeArticleen
dc.contributor.departmentSchool of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.en_GB
dc.identifier.journalProteomics. Clinical applicationsen_GB
dc.description.provinceLeinsteren
html.description.abstractChronic allograft nephropathy (CAN) remains the leading cause of renal graft loss after the first year following renal transplantation. This study aimed to identify novel urinary proteomic profiles, which could distinguish and predict CAN in susceptible individuals.


This item appears in the following Collection(s)

Show simple item record